The cancer diagnostics company is hours away from losing funding for its tests through the US Medicare system.
Software-as-a-service company's revenues supported by high interest rate environment.
The move brings the number of New Zealand companies solely listed on the ASX to 18.
Legal challenge among options after its hero product was struck off the Medicare subsidy list; by August the company will know more about its fate in the critical US market.
Data centres are hot as AI boosts demand, but One NZ feels corporate spending slump.
Board and management ‘accept and apologise for these long standing failings’, chair Julian Cook says.
Full-year results out this morning show company’s hopes are pinned on approval – but it has some backup plans.
Net profit declined 95% to $24 million in the year ended March 31, following asset sale the previous year.
But CEO Gary Miles warns against extrapolating current ‘rest of world’ segment growth to core NZ/Aus/UK markets.
Aucklanders can count on higher public transport tariffs and congestion charging, though tapping into Govt coffers could prove a speed bump.